Lataa...
Targeting tumor cell metabolism via the mevalonate pathway: Two hits are better than one
Statins are promising anticancer agents that target the mevalonate pathway. Tumor cells are sensitive to depletion of mevalonate-derived products but this activity triggers a homeostatic feedback loop that blunts statin efficacy. We showed that dipyridamole inhibits this feedback response and potent...
Tallennettuna:
| Julkaisussa: | Mol Cell Oncol |
|---|---|
| Päätekijät: | , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Taylor & Francis
2014
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4905210/ https://ncbi.nlm.nih.gov/pubmed/27308369 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/23723548.2014.969133 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|